About Profound Medical
Profound Medical is a company based in Toronto (Canada) founded in 2008.. Profound Medical has raised $37.73 million across 12 funding rounds from investors including Stifel, BDC and Cormark Securities. The company has 142 employees as of December 31, 2024. Profound Medical offers products and services including TULSA-PRO and Sonalleve. Profound Medical operates in a competitive market with competitors including Insightec, HistoSonics, Theraclion, Carthera and SONIRE Therapeutics, among others.
- Headquarter Toronto, Canada
- Employees 142 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Profound Medical Corp
-
Annual Revenue
$10.17 M (USD)50.58as on Dec 31, 2024
-
Net Profit
$-26.49 M (USD)0.31as on Dec 31, 2024
-
EBITDA
$-30.59 M (USD)-17.63as on Dec 31, 2024
-
Total Equity Funding
$37.73 M (USD)
in 12 rounds
-
Latest Funding Round
$6.45 M (USD), Post-IPO
Dec 19, 2025
-
Investors
Stifel
& 7 more
-
Employee Count
142
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Profound Medical
Profound Medical is a publicly listed company on the TSX with ticker symbol PRN in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Profound Medical
Profound Medical offers a comprehensive portfolio of products and services, including TULSA-PRO and Sonalleve. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Device for MRI-guided ablation of prostate tissue in cancer treatment.
System for focused ultrasound interventions in various therapies.
Unlock access to complete
Unlock access to complete
Funding Insights of Profound Medical
Profound Medical has successfully raised a total of $37.73M across 12 strategic funding rounds. The most recent funding activity was a Post-IPO round of $6.45 million completed in December 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 12
- Last Round Post-IPO — $6.5M
-
First Round
First Round
(01 Jun 2008)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2025 | Amount | Post-IPO - Profound Medical | Valuation |
investors |
|
| Jan, 2024 | Amount | Post-IPO - Profound Medical | Valuation |
investors |
|
| Jul, 2020 | Amount | Post-IPO - Profound Medical | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Profound Medical
Profound Medical has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Stifel, BDC and Cormark Securities. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage life sciences companies are supported through venture capital investments.
|
Founded Year | Domain | Location | |
|
Prescription pharmaceuticals are acquired, licensed, and commercialized by the company.
|
Founded Year | Domain | Location | |
|
Diversified investment management services are provided globally.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Profound Medical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Profound Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Profound Medical Comparisons
Competitors of Profound Medical
Profound Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insightec, HistoSonics, Theraclion, Carthera and SONIRE Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided.
|
|
| domain | founded_year | HQ Location |
Tissue ablation is achieved through non-invasive ultrasound Histotripsy technology.
|
|
| domain | founded_year | HQ Location |
Provider of non-invasive robotic ultrasound therapy devices
|
|
| domain | founded_year | HQ Location |
Ultrasound-based medical devices for brain tumor treatment are developed.
|
|
| domain | founded_year | HQ Location |
High-intensity focused ultrasound systems for targeted cancer treatments are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Profound Medical
Frequently Asked Questions about Profound Medical
When was Profound Medical founded?
Profound Medical was founded in 2008.
Where is Profound Medical located?
Profound Medical is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Is Profound Medical a funded company?
Profound Medical is a funded company, having raised a total of $37.73M across 12 funding rounds to date. The company's 1st funding round was a Post-IPO of $46M, raised on Jun 01, 2008.
How many employees does Profound Medical have?
As of Dec 31, 2024, the latest employee count at Profound Medical is 142.
What is the annual revenue of Profound Medical?
Annual revenue of Profound Medical is $10.17M as on Dec 31, 2024.
What does Profound Medical do?
Profound Medical was founded in 2008 in Toronto, Canada, within the medical technology sector focused on oncology. Image-guided ablation systems for prostate cancer treatment are developed and provided by the company. Proprietary technology is utilized in the TULSA-PRO system, an AI-powered, MRI-guided, incision-free robotic platform designed for precise ablation of prostate tissue. Operations center on advancing non-invasive therapeutic solutions for urological conditions.
Who are the top competitors of Profound Medical?
Profound Medical's top competitors include Insightec, HistoSonics and Theraclion.
What products or services does Profound Medical offer?
Profound Medical offers TULSA-PRO and Sonalleve.
Is Profound Medical publicly traded?
Yes, Profound Medical is publicly traded on TSX under the ticker symbol PRN.
Who are Profound Medical's investors?
Profound Medical has 8 investors. Key investors include Stifel, BDC, Cormark Securities, Knight Therapeutics, and Bloom Burton & Co..
What is Profound Medical's ticker symbol?
The ticker symbol of Profound Medical is PRN on TSX.